-
Featured
Mindfulness-based Cognitive Therapy Shows Promise for Treating Depression in Chronically Ill Patients
Mass General researchers were part of the first group to investigate whether mindfulness-based cognitive therapy might relieve depression in people with chronic pain.
-
Featured
Women with Major Depression During Pregnancy Have High Rates of Recurrence During Their Child's Formative Years
Depression during pregnancy is highly likely to recur after delivery, Mass General researchers have determined. The finding implies that maternal depression is a major confounder when assessing the influence of prenatal antidepressant exposure on child neurodevelopment.
-
Featured
Effective Ketamine Dosages for Treatment-resistant Depression Identified
Ketamine has long been used as a general anesthetic, but more recent research has found it to be effective in rapidly relieving depression symptoms when given at low, subanesthetic doses. New research identifies two optimal dosages.
-
Psychiatric Disorders Not Associated With Incidental Findings in Medically Actionable Genes
Using the same approach as in a phenome-wide association study, Yen-Chen A. Feng, ScD, Jordan W. Smoller, MD, ScD, and colleagues systematically evaluated data on 15,181 individuals and did not identify any psychiatric manifestations of rare variations in medically actionable genes.
-
Growth Marks in Teeth May Identify Children at Risk of Mental Health Disorders
Rebecca V. Mountain, PhD, and Erin C. Dunn, ScD, MPH, of the Psychiatric and Neurodevelopmental Genetics Unit, and colleagues are the first to observe associations between maternal psychosocial factors and child tooth-based measures that could guide mental health interventions for children before symptoms develop.
-
Developing a Clinical Tool to Predict Suicide Risk
Clinician-researchers at the Center for Precision Psychiatry at Massachusetts General Hospital with colleagues at Harvard University, Harvard Medical School and Boston Children's Hospital have developed an algorithm to improve the prediction of suicide risk in clinical settings.
Depression Contributors
-
Cristina Cusin, MD
Assistant Professor in Psychiatry, Staff Psychiatrist, Depression Clinical and Research Program
Recent Article
Q&A with Dr. Cristina Cusin: What to Know About Esketamine and Ketamine Treatment
-
David Mischoulon, MD, PhD
Director, Depression Clinical and Research Program
Recent Article
Mindfulness-based Cognitive Therapy Shows Promise for Treating Depression in Chronically Ill Patients
-
Maurizio Fava, MD
Psychiatrist-In-Chief; Director, Division of Clinical Research of the MGH Research Institute, Executive Director, Clinical Trials Network and Institute (CTNI), Massachusetts General Hospital, Associate Dean for Clinical & Translational Research, Slater Family Professor of Psychiatry, Harvard Medical School
Recent Article
Esmethadone Safe and Tolerable in Phase 2a Trial in Major Depressive Disorder
Neuroscience Care at Mass General
Through a combination of unmatched expertise, creativity and compassion, Mass General Neuroscience relentlessly advances the fields of Neurosurgery, Neurology and Psychiatry to unleash our patients’ potential.